Skip to main content
Erschienen in:

11.09.2024 | Clinical Report

Liposarcoma of Maxilla- A Rare Case Report

verfasst von: Gautami Joshi, Aditya Mukim, Shivam Pandya, Hemant Saraiya, Anish Chowdhary, Shailee Mehta, VC Geethakrishna, Ishan Arora, Shashank Pandya

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 6/2024

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Sarcomas of the head and neck region account for less than 10% of soft tissue sarcomas, and comprise less than 1% of head and neck malignancies. Approximately 80% of sarcomas arise from soft tissue, with the remaining originating from bone or cartilage. Head and neck sarcomas typically occur more frequently in men.

Case report

Our patient was a 30 year old male who presented with a ulceroproliferative mass over the soft palate increasing in size over past 6 months. Punch biopsy of the lesion was suggestive of carcinosarcoma. MRI PNS was suggestive of 38 × 39 × 33 mm sized lobulated lesion involving soft palate on right side, crossing midline and displaces uvula. The lesion involved right side of hard palate, right retromolar trigone with abutment of right medial pterygoid. It was also suggestive of bilateral sub centimetric nodes involving bilateral level 2 neck nodes. The patient received 3 cycles neoadjuvant chemotherapy Ifosfamide and Doxorubicin and patient had no subjective response to chemotherapy with subjective increase in the size of lesion. MRI PNS post neoadjuvant chemotherapy was suggestive of 46 × 46 × 41 mm lobulated lesion involving right side of the soft palate crossing midline over to the left, involving right posterior hard palate and right retromolar trigone, tonsillar fossa and TL sulcus. CECT thorax was negative for lung metastasis. Our patient was a 30 year old male who presented with a ulceroproliferative mass over the soft palate increasing in size over past 6 months. Punch biopsy of the lesion was suggestive of carcinosarcoma. MRI PNS was suggestive of 38x39x33mm sized lobulated lesion involving soft palate on right side, crossing midline and displaces uvula. The lesion involved right side of hard palate, right retromolar trigone with abutment of right medial pterygoid. It was also suggestive of bilateral sub centimetric nodes involving bilateral level 2 neck nodes. The patient received 3 cycles neoadjuvant chemotherapy Ifosfamide and Doxorubicin and patient had no subjective response to chemotherapy with subjective increase in the size of lesion. MRI PNS post neoadjuvant chemotherapy was suggestive of 46 × 46 × 41 mm lobulated lesion involving right side of the soft palate crossing midline over to the left, involving right posterior hard palate and right retromolar trigone, tonsillar fossa and TL sulcus. CECT thorax was negative for lung metastasis.

Discussion

The patient underwent wide local excision with medial maxillectomy via a bilateral Weber-Ferguson incision with Diffenbach extension and sent for frozen. The margins were negative and free of tumor. Bilateral modified neck dissection type 3 was done for lymph node clearance. A bilateral temporalis flap was done for reconstruction of the defect with a temporary obturator placement. Sarcomas of the sinonasal region may present a diagnostic challenge, as their location in the sinuses or nasal cavity may lead to presenting symptoms such as epistaxis, nasal congestion, or sinus pain and pressure that may be attributed to more benign causes such as chronic sinusitis, sinonasal polyposis, or allergic rhinitis. The less common sinonasal sarcoma subtypes may present a diagnostic challenge as their histopathological characteristics may overlap, especially with variations in tumor grade or with dedifferentiation. Additionally, the ideal treatment modality may present a therapeutic challenge, as the response to radiation and/or chemotherapy may vary according to the sarcoma subtype. Surgery is considered to be the mainstay in the management of carcinosarcomas of head and neck. Based on the evidence presented herein, elective neck dissection should be considered to treat squamous cell carcinomas of the maxillary palate, ginigiva, and alveolus.
Literatur
1.
Zurück zum Zitat Yamaguchi S, Nagasawa H, Suzuki T, Fujii E, Iwaki H, Takagi M et al (2004) Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years. Clin Oral Investig 8(2):52–55CrossRefPubMed Yamaguchi S, Nagasawa H, Suzuki T, Fujii E, Iwaki H, Takagi M et al (2004) Sarcomas of the oral and maxillofacial region: a review of 32 cases in 25 years. Clin Oral Investig 8(2):52–55CrossRefPubMed
2.
Zurück zum Zitat Stavrakas M, Nixon I, Andi K, Oakley R, Jeannon JP, Lyons A et al (2016) Head and neck sarcomas: clinical and histopathological presentation, treatment modalities, and outcomes. J Laryngol Otol 130(9):850–859CrossRefPubMed Stavrakas M, Nixon I, Andi K, Oakley R, Jeannon JP, Lyons A et al (2016) Head and neck sarcomas: clinical and histopathological presentation, treatment modalities, and outcomes. J Laryngol Otol 130(9):850–859CrossRefPubMed
3.
Zurück zum Zitat Stepan K, Konuthula N, Khan M, Parasher A, Del Signore A, Govindaraj S et al (2017) Outcomes in adult sinonasal Rhabdomyosarcoma. Otolaryngol Head Neck Surg 157(1):135–141CrossRefPubMed Stepan K, Konuthula N, Khan M, Parasher A, Del Signore A, Govindaraj S et al (2017) Outcomes in adult sinonasal Rhabdomyosarcoma. Otolaryngol Head Neck Surg 157(1):135–141CrossRefPubMed
4.
Zurück zum Zitat Unsal AA, Chung SY, Unsal AB, Baredes S, Eloy JA (2017) A Population-based analysis of Survival for Sinonasal Rhabdomyosarcoma. Otolaryngol Head Neck Surg 157(1):142–149CrossRefPubMed Unsal AA, Chung SY, Unsal AB, Baredes S, Eloy JA (2017) A Population-based analysis of Survival for Sinonasal Rhabdomyosarcoma. Otolaryngol Head Neck Surg 157(1):142–149CrossRefPubMed
5.
Zurück zum Zitat Gerth DJ, Tashiro J, Thaller SR (2014) Pediatric sinonasal tumors in the United States: incidence and outcomes. J Surg Res 190(1):214–220CrossRefPubMed Gerth DJ, Tashiro J, Thaller SR (2014) Pediatric sinonasal tumors in the United States: incidence and outcomes. J Surg Res 190(1):214–220CrossRefPubMed
6.
Zurück zum Zitat Thompson CF, Kim BJ, Lai C, Grogan T, Elashoff D, St John MA et al (2013) Sinonasal rhabdomyosarcoma: prognostic factors and treatment outcomes. Int Forum Allergy Rhinol 3(8):678–683CrossRefPubMedPubMedCentral Thompson CF, Kim BJ, Lai C, Grogan T, Elashoff D, St John MA et al (2013) Sinonasal rhabdomyosarcoma: prognostic factors and treatment outcomes. Int Forum Allergy Rhinol 3(8):678–683CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Weiss SW (1996) Lipomatous tumors. Monogr Pathol 38:207–239PubMed Weiss SW (1996) Lipomatous tumors. Monogr Pathol 38:207–239PubMed
10.
Zurück zum Zitat Thorn AP, Daugaard S, Christensen LH, Christensen IJ, Petersen MM (2016) YKL-40 protein in osteosarcoma tumor tissue. APMIS 124(6):453–461CrossRefPubMed Thorn AP, Daugaard S, Christensen LH, Christensen IJ, Petersen MM (2016) YKL-40 protein in osteosarcoma tumor tissue. APMIS 124(6):453–461CrossRefPubMed
11.
Zurück zum Zitat Dahodwala MQ, Husain Q, Kanumuri VV, Choudhry OJ, Liu JK, Eloy JA (2013) Management of sinonasal hemangiopericytomas: a systematic review. Int Forum Allergy Rhinol 3(7):581–587CrossRefPubMed Dahodwala MQ, Husain Q, Kanumuri VV, Choudhry OJ, Liu JK, Eloy JA (2013) Management of sinonasal hemangiopericytomas: a systematic review. Int Forum Allergy Rhinol 3(7):581–587CrossRefPubMed
12.
Zurück zum Zitat Duval M, Hwang E, Kilty SJ (2013) Systematic review of treatment and prognosis of sinonasal hemangiopericytoma. Head Neck 35(8):1205–1210CrossRefPubMed Duval M, Hwang E, Kilty SJ (2013) Systematic review of treatment and prognosis of sinonasal hemangiopericytoma. Head Neck 35(8):1205–1210CrossRefPubMed
13.
Zurück zum Zitat Go¨tte K, Hormann K (2004) Sinonasal malignancy: what’s new? ORL J Otorhinolaryngol Relat Spec 66:85–97CrossRefPubMed Go¨tte K, Hormann K (2004) Sinonasal malignancy: what’s new? ORL J Otorhinolaryngol Relat Spec 66:85–97CrossRefPubMed
14.
Zurück zum Zitat Edland RW (1968) Liposarcoma: a retrospective study of fifteen cases. Am J Roengtgenol 103:778–791CrossRef Edland RW (1968) Liposarcoma: a retrospective study of fifteen cases. Am J Roengtgenol 103:778–791CrossRef
18.
Zurück zum Zitat Iqbal MS, Paleri V, Brown J et al (2015) Spindle cell carcinoma of the head and neck region: treatment and outcomes of 15 patients. Ecancermedicalscience 9:1–9CrossRef Iqbal MS, Paleri V, Brown J et al (2015) Spindle cell carcinoma of the head and neck region: treatment and outcomes of 15 patients. Ecancermedicalscience 9:1–9CrossRef
19.
Zurück zum Zitat Elective neck dissection versus observation for cN0 neck of squamous cell carcinoma primarily located in the maxillary gingiva and alveolar ridge: a retrospective study of 129 cases Zhien Feng, MD, PhD, Jian Nan Li, MD, Chuan Zhen Li, MD, and Chuan Bin Guo, MD, PhD Peking University, Beijing, China Elective neck dissection versus observation for cN0 neck of squamous cell carcinoma primarily located in the maxillary gingiva and alveolar ridge: a retrospective study of 129 cases Zhien Feng, MD, PhD, Jian Nan Li, MD, Chuan Zhen Li, MD, and Chuan Bin Guo, MD, PhD Peking University, Beijing, China
20.
Zurück zum Zitat Oral Maxillary Squamous Cell Carcinoma: Management of the Clinically Negative Neck David M. Montes, DDS,* and Brian, Schmidt L DDS, MD, PhD Oral Maxillary Squamous Cell Carcinoma: Management of the Clinically Negative Neck David M. Montes, DDS,* and Brian, Schmidt L DDS, MD, PhD
Metadaten
Titel
Liposarcoma of Maxilla- A Rare Case Report
verfasst von
Gautami Joshi
Aditya Mukim
Shivam Pandya
Hemant Saraiya
Anish Chowdhary
Shailee Mehta
VC Geethakrishna
Ishan Arora
Shashank Pandya
Publikationsdatum
11.09.2024
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 6/2024
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-024-05022-x

Neu im Fachgebiet HNO

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Kopf-Hals-Tumore: Lebensqualität von Langzeitüberlebenden

Eine aktuelle Studie des Universitätsklinikums Erlangen verdeutlicht, dass Langzeitüberlebende von Kopf-Hals-Tumoren eine geringe Symptomlast aufweisen. Die am häufigsten auftretenden Beschwerden – Müdigkeit, Angstzustände, Schläfrigkeit und Schmerzen – sollten von den behandelnden Ärztinnen und Ärzten gezielt adressiert werden.

Schlafapnoe – es lag an einer verbogenen Nasenscheidewand

Tritt eine obstruktive Schlafapnoe vor allem in einer bestimmten Seitenlage auf, kann dies auch an einem verbogenen Nasenseptum liegen. Eine Septumplastik lindert die Beschwerden mitunter deutlich.

Das alles ändert sich für Arztpraxen in 2025

  • 31.12.2024
  • EBM
  • Nachrichten

Ab Januar greifen jede Menge Neuerungen – ob im EBM, Arbeits- und Steuerrecht oder bei der digitalen Vernetzung. Darunter einige Verbesserungen, aber teils auch Mehraufwand. „Same procedure as every year?“ – Ein Überblick.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.